Trial Evaluating PCSK9 Antibody in Subjects With LDL Receptor Abnormalities

Clinical trial NCT01588496 · COMPLETED

Trial details

NCT number: NCT01588496
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Homozygous Familial Hypercholesterolemia

Start date: 2012-04-05
Primary completion: 2014-01-31
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.